Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.160
-0.150 (-11.45%)
At close: Mar 6, 2026, 4:00 PM EST
1.190
+0.030 (2.59%)
After-hours: Mar 6, 2026, 7:54 PM EST
Aspire Biopharma Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 3.1 | 1.07 | 0.29 | 0.42 |
| Research & Development | 0.94 | 0.14 | 0.07 | 0.18 |
| Operating Expenses | 4.04 | 1.21 | 0.36 | 0.6 |
| Operating Income | -4.04 | -1.21 | -0.36 | -0.6 |
| Interest Expense | -2.4 | -0.1 | - | - |
| Pretax Income | -20.54 | -1.31 | -0.36 | -0.6 |
| Income Tax Expense | - | 0 | 0 | 0 |
| Net Income | -20.54 | -1.31 | -0.36 | -0.6 |
| Net Income to Common | -20.54 | -1.31 | -0.36 | -0.6 |
| Shares Outstanding (Basic) | 1 | 11 | 443 | - |
| Shares Outstanding (Diluted) | 1 | 11 | 443 | - |
| Shares Change (YoY) | -99.72% | -97.52% | - | - |
| EPS (Basic) | -16.59 | -0.12 | -0.00 | - |
| EPS (Diluted) | -16.59 | -0.12 | -0.00 | - |
| EBIT | -4.04 | -1.21 | -0.36 | -0.6 |
Source: S&P Capital IQ. Standard template.
Financial Sources.